Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Lung Cancer. 2015 Sep;16(5):e105-9. doi: 10.1016/j.cllc.2015.03.002. Epub 2015 Mar 25.

Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling.

Author information

  • 1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • 2Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • 3Foundation Medicine, Inc, Cambridge, MA.
  • 4Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: dbcosta@bidmc.harvard.edu.

KEYWORDS:

Anaplastic lymphoma kinase; C-ros oncogene 1; Hepatocyte growth factor receptor; Mutation; Next-generation sequencing

PMID:
25922291
PMCID:
PMC4418215
DOI:
10.1016/j.cllc.2015.03.002
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center